Comparison of the effects of nebulised and inhaled salbutamol on breathlessness in severe COPD

Respiratory Medicine

Volumn 99, Issue 3, 2005, Pages 372-376

  Poole, P J ^a   Saini, R ^a   Brodie, S M ^a   Black, P N ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Breathlessness; COPD; Nebulised; Salbutamol

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; IPRATROPIUM BROMIDE; LONG ACTING DRUG; SALBUTAMOL; SHORT ACTING DRUG;

ADULT; AGED; ARTICLE; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG RESPONSE; DRUG WITHDRAWAL; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATION SPACER; INTERMETHOD COMPARISON; LOCAL ANESTHESIA; LUNG FUNCTION; MALE; METERED DOSE INHALER; NEBULIZATION; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOPICAL ANESTHESIA; VISUAL ANALOG SCALE;

AGED; AGED, 80 AND OVER; ALBUTEROL; ANESTHETICS, LOCAL; BRONCHODILATOR AGENTS; CROSS-OVER STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LIDOCAINE; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; PRILOCAINE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATION DISORDERS; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 13944254128     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2004.08.002     Document Type: Article

References (15)

1. P.J. Poole S.M. Brodie J.M. Stewart P.N. Black The effects of nebulised isotonic saline and terbutaline on breathlessness in severe chronic obstructive pulmonary disease (COPD) Aust Nz J Med 28 1998 322-326
2. R.M. Schwartzstein K. Lahive A. Pope et al. Cold facial stimulation reduces breathlessness induced in normal subjects Am Rev Respir Dis 136 1987 58-61
3. D.P. Spence D.R. Graham J. Ahmed et al. Does cold air affect exercise capacity and dyspnea in stable chronic obstructive pulmonary disease Chest 103 1993 693-696
4. B.R. Celli G.L. Snider J. Heffner et al. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 152 1995 S77-S120
5. G.H. Guyatt M. Townsend L.B. Berman J.L. Keller A comparison of Likert and visual analogue scales for measuring change in function J Chron Dis 40 1987 1129-1133
6. D.J. Karras M.E. Sammon C.A. Terregino B.L. Lopez S.K. Griswold G.K. Arnold Clinically meaningful changes in quantitative measures of asthma severity Acad Emerg Med 7 2000 327-334
7. S. Booth M.J. Kelly N.P. Cox L. Adams A. Guz Does oxygen help dyspnea in patients with cancer? Am J Respir Crit Care Med 153 1996 1515-1518
8. H.P. Liss B.J. Grant The effect of nasal flow on breathlessness in patients with chronic obstructive pulmonary disease Am Rev Respir Dis 137 1988 1285-1288
9. T. Dolfin P. Duffty D. Wilkes S. England H. Bryan Effects of a face mask and pneumotachograph on breathing in sleeping infants Am Rev Respir Dis 128 1983 977-979
10. D.E. O'Donnell S. Revill K.A. Webb Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease Am J Respir Crit Care Med 164 2001 770-777
11. A.S. Vathenen J.R. Britton P. Ebden J.B. Cookson H.J. Wharrad A.E. Tattersfield High-dose albuterol in severe chronic airflow limitation Am Rev Respir Dis 138 1988 850-855
12. N.C.G. Hansen Terbutaline as powder inhalation from Bricanyl turbuhaler compared to terbutaline as nebulizer solution in severe chronic airways obstruction Eur Respir J 2 1989 716-720
13. A. Mandelberg E. Chen N. Noviski I.E. Priel Nebulized wet aerosol treatment in emergency department-is it essential? Comparison with large spacer device for metered-dose inhaler Chest 112 1997 1501-1505
14. P.J. Poole B. Bagg S.M. Brodie P.N. Black Characteristics of patients admitted to hospital with chronic obstructive pulmonary disease NZ Med J 110 1997 272-275
15. N. Eiser K. Angus S. McHale The role of domiciliary nebulizers in managing patients with severe COPD Respir Med 95 2001 265-274